Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 288 entries
View as:

Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT03063697 Org: User:
Start: 11/30/15 End: 12/31/20 Due: 12/31/21

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05189288 Org: User:
Start: 01/14/22 End: 04/15/22 Due: 04/15/23

The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03641352 Org: User:
Start: 05/02/18 End: 11/30/22 Due: 11/30/23

The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04667975 Org: User:
Start: 05/21/20 End: 08/30/24 Due: 08/30/25

Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)

Phase: N/A Priority: Normal
NCT ID: NCT04224350 Org: User:
Start: 12/17/18 End: 11/30/20 Due: 11/30/21

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05544214 Org: User:
Start: 10/21/22 End: 11/17/22 Due: 11/17/23

Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930

Phase: N/A Priority: Normal
NCT ID: NCT05207761 Org: User:
Start: 01/19/22 End: 11/02/22 Due: 11/02/23

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06399068 Org: User:
Start: 09/19/22 End: 10/05/22 Due: 10/05/23

The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1

Phase: N/A Priority: Normal
NCT ID: NCT04840745 Org: User:
Start: 04/30/21 End: 11/30/21 Due: 11/30/22

CKD-337(2) Drug-drug Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT02422030 Org: User:
Start: 03/17/15 End: 04/30/15 Due: 04/30/16

Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029

Phase: N/A Priority: Normal
NCT ID: NCT05897216 Org: User:
Start: 07/14/23 End: 08/08/23 Due: 08/08/24

CKD-11101 Phase 3 SC Study

Phase: N/A Priority: Normal
NCT ID: NCT03431623 Org: User:
Start: 05/31/15 End: 08/31/17 Due: 08/31/18

A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843

Phase: N/A Priority: Normal
NCT ID: NCT04805606 Org: User:
Start: 04/30/21 End: 12/24/21 Due: 12/24/22

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination

Phase: N/A Priority: Normal
NCT ID: NCT01663038 Org: User:
Start: 12/31/10 End: 09/30/11 Due: 09/30/12

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04075643 Org: User:
Start: 09/19/19 End: 10/30/19 Due: 10/30/20

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Phase: N/A Priority: Normal
NCT ID: NCT06088017 Org: User:
Start: 10/23/23 End: 01/22/24 Due: 01/22/25

Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT05043467 Org: User:
Start: 01/02/19 End: 06/19/20 Due: 06/19/21

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Phase: N/A Priority: Normal
NCT ID: NCT04312698 Org: User:
Start: 08/29/19 End: 06/18/21 Due: 06/18/22

A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01340248 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Phase: N/A Priority: Normal
NCT ID: NCT03928470 Org: User:
Start: 01/29/19 End: 12/20/19 Due: 12/20/20

Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01028859 Org: User:
Start: 12/31/09 End: 04/30/11 Due: 04/30/12

A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05108038 Org: User:
Start: 10/07/21 End: 02/28/22 Due: 02/28/23

Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04478097 Org: User:
Start: 07/14/20 End: 01/01/21 Due: 01/01/22

Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981

Phase: N/A Priority: Normal
NCT ID: NCT06954766 Org: User:
Start: 05/12/25 End: 11/30/25 Due: 11/30/26

Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial

Phase: N/A Priority: Normal
NCT ID: NCT01496261 Org: User:
Start: 08/31/11 End: 09/30/11 Due: 09/30/12